Table 1: Anthropometric and clinical characteristics of study population.

Factor Group A (n = 13) Group B (n = 11) Group C (n = 130) p-value
Demographics
Age (years) 68 (66-75) 75 (58-80) 71 (59-78) 0.809
Male sex 9 (69.2) 6 (54.5) 81 (62.3) 0.760
Medical admission 9 (69.2) 11 (100) 85 (65.4) 0.061
Prior LOS in ward (days) 12 (1-37)* 3 (1-5) 2 (1-4) 0.023
APACHE IIa 19.5 ± 6.3 22.7 ± 5.9 18.7 ± 6.9 0.162
SOFAa 8 (7.5-11) 9 (8-11) 8 (6-10) 0.168
Comorbidities
Diabetes mellitus 5 (38.5) 2 (18.2) 48 (36.9) 0.450
Chronic renal failure 3 (23.1) 1 (9.1) 21 (16.1) 0.650
Chronic lung disease 0*# 5 (45.5) 39 (30) 0.032
Chronic heart failure 6 (46.1) 2 (18.2) 27 (20.7) 0.107
Chronic neuro-psychiatric disorders 0 2 (18.2) 19 (14.6) 0.309
Immunosuppressionb 0 1 (9.1) 4 (3.1) 0.440

*Significantly different compared to Group C; #Significantly different compared to Group B; Data are no. (%) of patients or median (IQR) unless otherwise stated.

LOS: Length of Stay; APACHE: Acute Physiology and Chronic Health Evaluation; SOFA: Sequential Organ Failure Assessment; IQR: Interquartile Range.

aAt ICU admission; bNeutropenia (neutrophil count < 1000/mm3); immunosuppressant medication (including corticosteroids), splenectomy.